Methasulfocarb

CAS No. 66952-49-6

Methasulfocarb( —— )

Catalog No. M20791 CAS No. 66952-49-6

Methasulfocarb is a fungicide bactericide compound.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 76 In Stock
2MG 32 In Stock
5MG 51 In Stock
10MG 79 In Stock
25MG 153 In Stock
50MG 221 In Stock
100MG 328 In Stock
200MG 458 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Methasulfocarb
  • Note
    Research use only, not for human use.
  • Brief Description
    Methasulfocarb is a fungicide bactericide compound.
  • Description
    Methasulfocarb is a fungicide bactericide compound.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    66952-49-6
  • Formula Weight
    261.32
  • Molecular Formula
    C9H11NO4S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CNC(=O)Sc1ccc(OS(C)(=O)=O)cc1
  • Chemical Name
    Carbamothioic acid methyl- S-(4-((methylsulfonyl)oxy)phenyl) ester

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Ohmori K Watanabe Y . Efficacy of S-(4-methylsulfonyloxyphenyl) N-methylthiocarbamate (methasulfocarb) for control of bacterial seedling rot of rice caused by Pseudomonas glumae Kurita et Tabei.[J]. Annals of the Phytopathological Society of Japan 1986 52(1):78-81.
molnova catalog
related products
  • Nyasol

    Nyasol may have potential to be developed as medicines for the treatment of allergies by inhibiting the activation of mast cells.

  • Quinocetone

    Quinocetone is an animal growth promoter?and potential anti-tumor activity.

  • Tigogenin

    Tigogenin is one of steroidal sapogenins which is widely used for synthesizing steroid drugs.?It might have protective effect on bone and be helpful in preventing the development of osteoporosis.